Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 64.05
+2.05 (3.31%)
Mar 10, 2026, 3:00 PM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 7.00 billion as of March 10, 2026. Its market cap has increased by 67.54% in one year.
Market Cap
7.00B
Enterprise Value
6.88B
Revenue
1.22B
Ranking
n/a
PE Ratio
35.78
Stock Price
64.05
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 7.00B, a decrease of -27.15%. That is a compound annual growth rate of -6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 6.78B | -0.24% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 6.76B |
| Guizhou Bailing Group Pharmaceutical | 7.04B |
| Tibet Duo Rui Pharmaceutical | 6.62B |
| Heilongjiang ZBD Pharmaceutical | 7.20B |
| ChengDa Pharmaceuticals | 6.48B |
| Jiangsu Lianhuan Pharmaceutical | 6.47B |
| Jiuzhitang | 7.35B |
| Beijing SL Pharmaceutical | 6.43B |